Science by the EDQM

The highly qualified EDQM staff regularly contributes to scientific articles published in a variety of journals. The list below presents the articles published in 2025.

External publications

  1. Domínguez Gil B., López-Fraga M., Muller E. et al. (2025), “Santander global summit in transplantation: supporting global convergence in the shared goals of sufficiency, transparency, and oversight”, Transplantation 109(1): 2-6, January 2025.
  2. Adamec M., Ahn C., Albreht K. et al. (2025), “Santander statement: towards global convergence in transplantation: sufficiency, transparency, and oversight”, Transplantation 109(1): 7-9, January 2025.
  3. Martin D. E., Capron A. M., Fadhil R. A. S. et al. (2025), “Supporting financial neutrality in donation of organs, cells, and tissues”, Transplantation 109(1): 48-59, January 2025.
  4. Martin D. E., Assche K. (Van), Cervantes L. et al. (2025), “Toward equity in global access to SoHO-based therapies: recommendations for action”, Transplantation 109(1): 60-72, January 2025.
  5. Martin D. E., Capron A. M., Fadhil R. A. S. et al. (2025), “Prevention of trafficking in organs, tissues, and cells”, Transplantation 109(1): 88-97, January 2025.
  6. Prax M., Debes L., Chudy M. et al. (2025), “Implementation of a blood proficiency testing scheme for bacterial screening of platelet components”, Vox Sanguinis 120(4): 401-410, April 2025.
  7. Viviani L., Vandeputte J., Smith D. et al. (2025), “Global availability of critical reagents for biologicals testing – Current status, challenges and possible solutions”, Biologicals (90) 101821, May 2025.
  8. Vanhee C., Deconinck E., George M. (2025), “The occurrence of illicit smart drugs or nootropics in Europe and Australia and their associated dangers: results from a market surveillance study by 12 official medicines control laboratories”, Journal of Xenobiotics 15(3) 88, June 2025.
  9. Pflieger M., Sepich A., Harriague J. et al. (2025), “Innovation in blood establishment processes, Strasbourg, 2025: a conference report”, Blood Transfusion 24(1), October 2025.
  10. Mendoza Barrios M., Deconinck E., Vanhee C. et al. (2025), “SARMs, metabolic modulators and growth hormone secretagogues in suspected illegal medicines, bought as sport performance enhancers: a retro-and prospective study within the GEON”, Drug Testing and Analysis 17(10): 2078-2085, October 2025.
  11. Khan A. S., Mallet L., Blümel J. et al. (2025), “Report of the fourth conference on next-generation sequencing (NGS) for adventitious virus detection in biologics for humans and animals: validation and implementation of NGS”, Biologicals (92) 101859, November 2025.
  12. Feavers I., Lei D., Milne C. et al. (2025), “Conference report WHO informal consultation on the draft WHO Guideline on the phasing out of animal tests for the quality control of biological products”, Biologicals (92) 101862, November 2025.
  13. Doerr P. and Lery F.-X. (2025), “Gestion des pénuries de médicaments en Europe – Rôle de l’EDQM”, L’Observatoire (75), December 2025.

The Methodological guide to select medicines at risk of shortages aims to equip national competent authorities and hospital and community pharmacists with a structured approach for identifying medicines that could become scarce during public health emergencies. Once finalised, the guide will support strategic planning by helping determine which products can be safely prepared in pharmacies when industrially manufactured medicines are unavailable.

To provide practical tools during active shortages, the EDQM has also set up the European Drug Shortages Formulary (EDSForm). Its monographs offer standardised methods for preparing and controlling unlicensed pharmaceutical preparations that can temporarily replace essential medicines. This long-term, proactive resource is complemented by technical recommendations from the EDSForm Working Party (EDSForm WP), providing short-term, reactive guidance for preparing extemporaneous or stock formulations when no EDSForm monograph exists.

Together, these initiatives strengthen Europe’s capacity to prevent, plan for and alleviate the impact of medicine shortages.

Pharmeuropa Bio & Scientific Notes

Pharmeuropa Bio & Scientific Notes seeks to disseminate knowledge on methods of analysis for pharmaceutical quality control, with a particular emphasis on the results obtained for pharmaceutical products. The journal publishes scientific articles related to biological standardisation with a primary focus on the EDQM Biological Standardisation Programme and the work of the European Pharmacopoeia (Ph. Eur.). It also includes reports on the establishment of key Ph. Eur. reference standards (BRP/CRS/BRR) for biologicals.

All articles published in Pharmeuropa Bio & Scientific Notes in 2025 can be found at: https://pbiosn.edqm.eu/app/pbiosn/search?title=2025&s=236787.

  1. Jouette S., Le Tallec D., Niewiadomska Cimicka A., Jorajuria S., Milne C. (2025), “Establishment of human anti-D immunoglobulin BRP2”, Pharmeur Bio Sci Notes, 2025: 1-8.
  2. Costanzo A., Hogwood J. (2025), “Ph. Eur. heparin low-molecular-mass for calibration CRS batch 6”, Pharmeur Bio Sci Notes, 2025: 9-12.

The Methodological guide to select medicines at risk of shortages aims to equip national competent authorities and hospital and community pharmacists with a structured approach for identifying medicines that could become scarce during public health emergencies. Once finalised, the guide will support strategic planning by helping determine which products can be safely prepared in pharmacies when industrially manufactured medicines are unavailable.

To provide practical tools during active shortages, the EDQM has also set up the European Drug Shortages Formulary (EDSForm). Its monographs offer standardised methods for preparing and controlling unlicensed pharmaceutical preparations that can temporarily replace essential medicines. This long-term, proactive resource is complemented by technical recommendations from the EDSForm Working Party (EDSForm WP), providing short-term, reactive guidance for preparing extemporaneous or stock formulations when no EDSForm monograph exists.

Together, these initiatives strengthen Europe’s capacity to prevent, plan for and alleviate the impact of medicine shortages.

View previous content
View next content